Etravirine Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Etravirine is used along with other medications to treat human immunodeficiency virus (HIV) infection in adults and children 2 years of age and older who no longer benefit from taking other HIV medications. Etravirine is in a class of medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs).Etravirine Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Etravirine Nitroso CAS NO:NA chemically represented as N-(4-Amino-5-bromo-6-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl)-N-(4-cyanophenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Etravirine Nitroso . We supply Etravirine Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143875 |
| CAS No | NA |
| Mol.F. | C23H30N2O4 |
| Mol.Wt. | 398.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143876 |
| CAS No | NA |
| Mol.F. | C36H62N2O13 |
| Mol.Wt. | 730.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143877 |
| CAS No | NA |
| Mol.F. | C36H65N3O14 |
| Mol.Wt. | 763.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143878 |
| CAS No | NA |
| Mol.F. | C36H64N2O14 |
| Mol.Wt. | 748.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143879 |
| CAS No | NA |
| Mol.F. | C9H12N2O3 |
| Mol.Wt. | 196.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143880 |
| CAS No | NA |
| Mol.F. | C25H21N5O5 |
| Mol.Wt. | 471.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143881 |
| CAS No | NA |
| Mol.F. | C28H28N6O5 |
| Mol.Wt. | 528.57g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143882 |
| CAS No | NA |
| Mol.F. | C12H13N3O2 |
| Mol.Wt. | 231.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143883 |
| CAS No | NA |
| Mol.F. | C11H18N6O3S2 |
| Mol.Wt. | 346.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143884 |
| CAS No | NA |
| Mol.F. | C4H8N4O3 |
| Mol.Wt. | 160.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143885 |
| CAS No | NA |
| Mol.F. | C4H7N3O3S |
| Mol.Wt. | 177.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143886 |
| CAS No | NA |
| Mol.F. | C12H20N6O4S2 |
| Mol.Wt. | 376.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143887 |
| CAS No | NA |
| Mol.F. | C11H17N5O4S2 |
| Mol.Wt. | 347.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143888 |
| CAS No | NA |
| Mol.F. | C15H24N8O5S3 |
| Mol.Wt. | 492.59 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143889 |
| CAS No | NA |
| Mol.F. | C20H32N8O3S4 |
| Mol.Wt. | 560.77 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143890 |
| CAS No | NA |
| Mol.F. | C11H19N5O2S2 |
| Mol.Wt. | 317.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |